National Storage Mechanism | Additional information

31 January 2023

Oberon Investments Group Plc

("Oberon" or the "Company" or the "Group")

Total Voting Rights

In accordance with the FCA's Disclosure Guidance and Transparency Rules, as at 31 January 2023, the Company's issued share capital consists of 520,249,641 Ordinary Shares of 0.5p, each with one voting right. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of voting rights in the Company is 520,249,641.

The above figure of 520,249,641 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

-ENDS-

Enquiries:

Oberon Investments Group plc Simon McGivern / John Beaumont	020 3179 5300
Novum Securities Limited (AQSE Corporate Adviser and Broker to the Company) Richard Potts, George Duxberry	020 7399 9400
Oberon Capital (Broker to the Company) Mike Seabrook, Nick Lovering	020 3179 5300

Notes for editors

Oberon operates in the UK wealth and fund management sector and in the corporate broking and financial advisory sectors. Since Oberon Investments Ltd was established in April 2017, Oberon group's FUMA have grown to in excess of £1 billion as at 30 September 2022. This has been achieved organically by adding new clients and new fund managers, attracted by the emerging brand and by a number of small, selective and accretive acquisitions. Oberon Capital, the corporate broking division, provides advice and raises capital for companies from seed and early-stage funding through to IPO and beyond.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END